Old Web
English
Sign In
Acemap
>
authorDetail
>
Panagiotis-Petros Lialios
Panagiotis-Petros Lialios
National and Kapodistrian University of Athens
Drug
Medicine
Pharmacology
Monoclonal antibody
anticancer treatment
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review.
2021
Frontiers in Oncology
Dimitrios C. Ziogas
Dimitrios Mandellos
Charalampos Theocharopoulos
Panagiotis-Petros Lialios
Spyros Bouros
Paolo A. Ascierto
Helen Gogas
Show All
Source
Cite
Save
Citations (0)
Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond
2021
Vaccine
Charalampos Theocharopoulos
Panagiotis-Petros Lialios
Michael Samarkos
Helen Gogas
Dimitrios C. Ziogas
Show All
Source
Cite
Save
Citations (1)
An overview of antibody–drug conjugates in oncological practice:
2020
Therapeutic Advances in Medical Oncology
Charalampos Theocharopoulos
Panagiotis-Petros Lialios
Helen Gogas
Dimitrios C. Ziogas
Show All
Source
Cite
Save
Citations (8)
1